OrbiMed
OrbiMed is one of the world's largest healthcare-dedicated investment firms. They invest across the full spectrum of healthcare, from early-stage venture capital to public equities and credit, with deep expertise in biopharmaceuticals, medical devices, and healthcare services.
Website
https://www.orbimed.comLocation
New York, New York, USA
Founded
1989
AUM
$18B+
Investment Range
$10M - $200M+
Portfolio Companies
1
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth
Investment Thesis
OrbiMed invests in companies across the healthcare spectrum, from drug discovery to healthcare services. Their multi-stage approach allows them to support companies throughout their lifecycle, from formation through IPO and beyond, bringing deep industry expertise and an extensive network to portfolio companies.
Team
Partners / Managing Directors (Health & Bio Focus)
- Sven Hoppe, MD, PhD - Managing Partner
- Carl Gordon, PhD, CFA - Managing Partner
- Jonathan Silverstein - Managing Partner
- Carter Neild - Managing Partner
- Geoffrey Hsu - Managing Partner
Other Key Team Members
- Large global team with offices in NYC, San Francisco, Hong Kong, Mumbai
- Investment team includes MDs, PhDs, former pharma executives
Focus Areas
- Biopharmaceuticals
- Biotechnology
- Medical devices
- Healthcare services
- Healthcare IT
- Diagnostics
- Life science tools
Notable Investments
- Mirador Therapeutics - $400M funding round (2024)
- One of the most active healthcare investors globally
- Strong track record across therapeutic areas
Notable Exits
- Numerous IPOs annually across biopharma
- Multiple M&A exits above $1B
- Leading returns in healthcare venture
Sources
- https://www.orbimed.com
- https://www.orbimed.com/team
- PitchBook
- SEC filings
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Mirador Therapeutics | San Diego, California, USA | 2023 | therapeuticsbiotech+3 |